160 related articles for article (PubMed ID: 22041175)
1. Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.
Gaggini F; Laleu B; Orchard M; Fioraso-Cartier L; Cagnon L; Houngninou-Molango S; Gradia A; Duboux G; Merlot C; Heitz F; Szyndralewiez C; Page P
Bioorg Med Chem; 2011 Dec; 19(23):6989-99. PubMed ID: 22041175
[TBL] [Abstract][Full Text] [Related]
2. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
Laleu B; Gaggini F; Orchard M; Fioraso-Cartier L; Cagnon L; Houngninou-Molango S; Gradia A; Duboux G; Merlot C; Heitz F; Szyndralewiez C; Page P
J Med Chem; 2010 Nov; 53(21):7715-30. PubMed ID: 20942471
[TBL] [Abstract][Full Text] [Related]
3. Reactivity study of 1H-thieno[3,2-d][1,3]oxazine-2,4-dione toward the synthesis of bicyclic 3,4-dihydro-1H-thieno[3,2-e][1,4]diazepine-2,5-dione analogues.
Brouillette Y; Lisowski V; Fulcrand P; Martinez J
J Org Chem; 2007 Mar; 72(7):2662-5. PubMed ID: 17323999
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
5. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
[TBL] [Abstract][Full Text] [Related]
6. Novel pirfenidone analogues: synthesis of pyridin-2-ones for the treatment of pulmonary fibrosis.
Ammar YA; Ismail MM; El-Sehrawi HM; Noaman E; Bayomi AH; Shawer TZ
Arch Pharm (Weinheim); 2006 Aug; 339(8):429-36. PubMed ID: 16832818
[TBL] [Abstract][Full Text] [Related]
7. Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.
Revesz L; Blum E; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Neumann U; Rucklin G
Bioorg Med Chem Lett; 2006 Jan; 16(2):262-6. PubMed ID: 16249085
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Bioactive 3,4-Dihydro-2 H-naphtho[2,3- b][1,4]oxazine-5,10-dione and 2,3,4,5-Tetrahydro-1 H-naphtho[2,3- b]azepine-6,11-dione Derivatives via the Copper-Catalyzed Intramolecular Coupling Reaction.
You H; Vegi SR; Lagishetti C; Chen S; Reddy RS; Yang X; Guo J; Wang C; He Y
J Org Chem; 2018 Apr; 83(7):4119-4130. PubMed ID: 29546756
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
Belema M; Bunker A; Nguyen VN; Beaulieu F; Ouellet C; Qiu Y; Zhang Y; Martel A; Burke JR; McIntyre KW; Pattoli MA; Daloisio C; Gillooly KM; Clarke WJ; Brassil PJ; Zusi FC; Vyas DM
Bioorg Med Chem Lett; 2007 Aug; 17(15):4284-9. PubMed ID: 17540562
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists.
Richter HG; Adams DR; Benardeau A; Bickerdike MJ; Bentley JM; Blench TJ; Cliffe IA; Dourish C; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Monck NJ; Plancher JM; Roever S; Roffey JR; Taylor S; Vickers SP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1207-11. PubMed ID: 16361098
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
Sun L; Bera H; Chui WK
Eur J Med Chem; 2013 Jul; 65():1-11. PubMed ID: 23688695
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors.
Moure A; Orzáez M; Sancho M; Messeguer A
Bioorg Med Chem Lett; 2012 Dec; 22(23):7097-9. PubMed ID: 23079529
[TBL] [Abstract][Full Text] [Related]
13. Design of pyrazolo-pyrrolo-pyrazines and pyrazolo-pyrrolo-diazepines via AuCl₃-catalyzed and NaH-supported cyclization of N-propargyl pyrazoles.
Basceken S; Balci M
J Org Chem; 2015 Apr; 80(8):3806-14. PubMed ID: 25790184
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological action of some derivatives of pyrido-[1,4]-diazepine and pyrido-[2,3-d]-pyrimidine.
Sołoducho J; Mrozikiewicz A; Bobkiewicz-Kozłowska T; Olejnik A; Pieczyńska A
Pol J Pharmacol Pharm; 1985; 37(4):541-50. PubMed ID: 4080648
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis of pyrazolo[3,4-e][1,4]diazepine-4,7-diones with central nervous system activity].
Sprio V; Caronna S; Migliara O; Petruso S; Matera M
Farmaco; 1989 Sep; 44(9):809-18. PubMed ID: 2604835
[TBL] [Abstract][Full Text] [Related]
16. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines.
Gong YD; Dong MS; Lee SB; Kim N; Bae MS; Kang NS
Bioorg Med Chem; 2011 Sep; 19(18):5639-47. PubMed ID: 21855350
[TBL] [Abstract][Full Text] [Related]
17. A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.
Szewczyk JR; Laudeman CP; Sammond DM; Villeneuve M; Minick DJ; Grizzle MK; Daniels AJ; Andrews JL; Ignar DM
Bioorg Med Chem; 2010 Mar; 18(5):1822-33. PubMed ID: 20172734
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines.
Suzuki Y; Cluzeau J; Hara T; Hirasawa A; Tsujimoto G; Oishi S; Ohno H; Fujii N
Arch Pharm (Weinheim); 2008 Sep; 341(9):554-61. PubMed ID: 18763715
[TBL] [Abstract][Full Text] [Related]
19. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle.
Ellmark SH; Dusting GJ; Fui MN; Guzzo-Pernell N; Drummond GR
Cardiovasc Res; 2005 Feb; 65(2):495-504. PubMed ID: 15639489
[TBL] [Abstract][Full Text] [Related]
20. Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis.
Crestani B; Besnard V; Boczkowski J
Int J Biochem Cell Biol; 2011 Aug; 43(8):1086-9. PubMed ID: 21513813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
